Policy | April 09, 2026
India Pharma Conference 2026 to spotlight innovation, global partnerships in New Delhi
Discussions are likely to centre on how the country can move up the pharmaceutical value chain
Discussions are likely to centre on how the country can move up the pharmaceutical value chain
The state has received Rs. 84,000 crore investments in the sector over two years, positioning Hyderabad among the world’s leading life sciences clusters
While Drugs for Neglected Diseases initiative (DNDi) drives the R&D for neglected diseases, we collaborate with pharmaceutical companies at multiple stages, including sourcing promising molecules
The webinar series will showcase next-gen imaging technologies, global expert insights, and hands-on sessions on microscopy innovations
4th World Homoeopathy Summit at Palace of Westminster and University of Oxford spotlights integrative healthcare and global collaboration
Discussions will focus on how private space stations can improve access, repeatability and commercial feasibility for advanced biotech experiments
Scientists at the forum warned of an increasingly volatile health landscape
40+ most innovative startups with disruptive contributions across MedTech, Medical Devices, BioPharma, Cell and Gene Therapy, AI and ML, Nutraceuticals, and Biomarkers exhibited their cutting-edge solutions
The Union Budget makes a clear and timely choice by placing biopharma at the centre of India’s next manufacturing wave
The expanded agreement significantly widens the scope of integrated services across the entire drug development lifecycle
Subscribe To Our Newsletter & Stay Updated
